Related references
Note: Only part of the references are listed.Recent developments in the treatment of aggressive non-Hodgkin lymphoma
Anne-Sophie Michallet et al.
BLOOD REVIEWS (2009)
Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism
Galina V. Shurin et al.
JOURNAL OF IMMUNOLOGY (2009)
Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations
Ramon Kaneno et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer
Denise A. Yardley et al.
CLINICAL BREAST CANCER (2008)
Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: High response rate and disease eradication
Francesc Bosch et al.
CLINICAL CANCER RESEARCH (2008)
Human and murine model cell lines for dendritic cell biology evaluated
Suzanne F. G. van Helden et al.
IMMUNOLOGY LETTERS (2008)
Inducing antitumor T cell immunity: Comparative functional analysis of interstitial versus Langerhans dendritic cells in a human cell line model
Saskia J. A. M. Santegoets et al.
JOURNAL OF IMMUNOLOGY (2008)
Human dendritic cell line models for DC differentiation and clinical DC vaccination studies
Saskia J. A. M. Santegoets et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Taming cancer by inducing immunity via dendritic cells
A. Karolina Palucka et al.
IMMUNOLOGICAL REVIEWS (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line
Saskia J. A. M. Santegoets et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
A CD34+ human cell line model of myeloid dendritic cell differentiation:: evidence for a CD14+ CD11b+ Langerhans cell precursor
Saskia J. A. M. Santegoets et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
P-glycoprotein functions as a differentiation switch in antigen presenting cell maturation
S. S. Pendse et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma
Basak Oyan et al.
LEUKEMIA & LYMPHOMA (2006)
Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation
Rieneke van de Ven et al.
JOURNAL OF IMMUNOLOGY (2006)
Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer
A. Onyenadum et al.
JOURNAL OF CHEMOTHERAPY (2006)
Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium
HJ Long et al.
GYNECOLOGIC ONCOLOGY (2006)
Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer
Sergei Kusmartsev et al.
CANCER AND METASTASIS REVIEWS (2006)
Regulation of RelB expression during the initiation of dendritic cell differentiation
PJ Cejas et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
High mobility group box protein 1: An endogenous signal for dendritic cell maturation and Th1 polarization
D Messmer et al.
JOURNAL OF IMMUNOLOGY (2004)
Mitoxantrone - A review of its use in multiple sclerosis
LJ Scott et al.
CNS DRUGS (2004)
MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors
AJ Masterson et al.
BLOOD (2002)
Dendritic cell development and survival require distinct NF-κB subunits
F Ouaaz et al.
IMMUNITY (2002)
Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines
A van Loevezijn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Share Paper
